0001127602-22-009217.txt : 20220314 0001127602-22-009217.hdr.sgml : 20220314 20220314215209 ACCESSION NUMBER: 0001127602-22-009217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Day Daniel Patrick CENTRAL INDEX KEY: 0001638643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 22738676 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-03-10 0000882095 GILEAD SCIENCES, INC. GILD 0001638643 O'Day Daniel Patrick 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 Chairman & CEO Common Stock 2022-03-10 4 M 0 10800 0 A 247193 D Common Stock 2022-03-10 4 M 0 13203 0 A 260396 D Common Stock 2022-03-10 4 F 0 11052 57.92 D 249344 D Restricted Stock Unit 2022-03-10 4 M 0 10800 D Common Stock 10800 85772 D Restricted Stock Unit 2022-03-10 4 M 0 13203 D Common Stock 13203 72569 D Non-qualified Stock Option (Right to Buy) 57.92 2022-03-10 4 A 0 399235 0 A 2032-03-10 Common Stock 399235 399235 D Restricted Stock Unit 2022-03-10 4 A 0 64745 A Common Stock 64745 137314 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Amy Kim by Power of Attorney for Daniel O'Day 2022-03-14